170 related articles for article (PubMed ID: 27588480)
1. Lipid rafts promote liver cancer cell proliferation and migration by up-regulation of TLR7 expression.
Liu Y; Guo X; Wu L; Yang M; Li Z; Gao Y; Liu S; Zhou G; Zhao J
Oncotarget; 2016 Sep; 7(39):63856-63869. PubMed ID: 27588480
[TBL] [Abstract][Full Text] [Related]
2. Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma.
Mohamed FE; Al-Jehani RM; Minogue SS; Andreola F; Winstanley A; Olde Damink SW; Habtesion A; Malagó M; Davies N; Luong TV; Dhillon AP; Mookerjee RP; Dhar DK; Jalan R
Liver Int; 2015 Mar; 35(3):1063-76. PubMed ID: 24990399
[TBL] [Abstract][Full Text] [Related]
3. Targeting the raft-associated Akt signaling in hepatocellular carcinoma.
Liu Y; Lv JY; Shi JF; Yang M; Liu SH; Li ZW; Wang HB; Zhang SG; Liu ZW; Ding JB; Xu DP; Zhao JM
Biomed Res Int; 2014; 2014():836025. PubMed ID: 25243186
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of Toll-like receptor 7 expression in hepatitis-virus-related human hepatocellular carcinoma.
Lin KJ; Lin TM; Wang CH; Liu HC; Lin YL; Eng HL
Hum Pathol; 2013 Apr; 44(4):534-41. PubMed ID: 23069256
[TBL] [Abstract][Full Text] [Related]
5. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
6. Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line.
Das D; Sengupta I; Sarkar N; Pal A; Saha D; Bandopadhyay M; Das C; Narayan J; Singh SP; Chakrabarti S; Chakravarty R
BMC Infect Dis; 2017 Jan; 17(1):76. PubMed ID: 28088184
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib suppresses TGF-β responses by inducing caveolae/lipid raft-mediated internalization/degradation of cell-surface type II TGF-β receptors: Implications in development of effective adjunctive therapy for hepatocellular carcinoma.
Chung CL; Wang SW; Sun WC; Shu CW; Kao YC; Shiao MS; Chen CL
Biochem Pharmacol; 2018 Aug; 154():39-53. PubMed ID: 29678520
[TBL] [Abstract][Full Text] [Related]
8. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
9. HSP70 enhances macrophage phagocytosis by interaction with lipid raft-associated TLR-7 and upregulating p38 MAPK and PI3K pathways.
Wang R; Town T; Gokarn V; Flavell RA; Chandawarkar RY
J Surg Res; 2006 Nov; 136(1):58-69. PubMed ID: 16979664
[TBL] [Abstract][Full Text] [Related]
10. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
[TBL] [Abstract][Full Text] [Related]
11. A896G and C1196T Polymorphisms Within the TLR4 Gene Abate Toll-Like Receptor 4-Mediated Signaling in HepG2 Cells.
Huang C; Zhang H; Bai R; Wang L; Lv J
DNA Cell Biol; 2017 Nov; 36(11):1029-1038. PubMed ID: 28945461
[TBL] [Abstract][Full Text] [Related]
12. TLR7/8 agonists promote NK-DC cross-talk to enhance NK cell anti-tumor effects in hepatocellular carcinoma.
Zhou Z; Yu X; Zhang J; Tian Z; Zhang C
Cancer Lett; 2015 Dec; 369(2):298-306. PubMed ID: 26433159
[TBL] [Abstract][Full Text] [Related]
13. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma-specific expression of P2Y11 receptor and its contribution in ATP-induced purinergic signalling and cell migration in human hepatocellular carcinoma cells.
Khalid M; Brisson L; Tariq M; Hao Y; Guibon R; Fromont G; Mortadza SAS; Mousawi F; Manzoor S; Roger S; Jiang LH
Oncotarget; 2017 Jun; 8(23):37278-37290. PubMed ID: 28418839
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of microRNA-27b in hepatocellular carcinoma.
He S; Zhang J; Lin J; Zhang C; Sun S
Mol Med Rep; 2016 Mar; 13(3):2801-8. PubMed ID: 26846382
[TBL] [Abstract][Full Text] [Related]
16. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
17. NOR1 promotes hepatocellular carcinoma cell proliferation and migration through modulating the Notch signaling pathway.
You K; Sun P; Yue Z; Li J; Xiong W; Wang J
Exp Cell Res; 2017 Mar; 352(2):375-381. PubMed ID: 28232113
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
19. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.
Qiu H; Zhang X; Ni W; Shi W; Fan H; Xu J; Chen Y; Ni R; Tao T
Dig Dis Sci; 2016 Mar; 61(3):795-805. PubMed ID: 26553251
[TBL] [Abstract][Full Text] [Related]
20. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
